Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Richman

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
BMC Infectious Diseases|March 29, 2019
A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinibKatya Prakash, Douglas Richman
Current Opinion in HIV and AIDS|April 9, 2013
How to best measure HIV reservoirs?Christine Rouzioux, Douglas Richman
Antiviral Therapy|October 31, 2022
Preface: Special Collection Commemorating John C. MartinStephen Locarnini, Douglas Richman, Richard Whitley
Open Forum Infectious Diseases|July 24, 2019
<i>Myroides injenensis</i> Bacteremia and Severe CellulitisStephanie LaVergne, Thaidra Gaufin, Douglas Richman
AIDS Research and Human Retroviruses|March 20, 2003
A new perspective on V3 phenotype predictionSatish Pillai, Benjamin Good, Douglas Richman, et al.
Antiviral Therapy|September 13, 2006
The XIVth International HIV Drug Resistance Workshop, Quebec City, Canada, June 2005Charles Boucher, Brendan Larder, John Mellors, et al.
Antiviral Therapy|May 17, 2007
Key reports from the XV International HIV Drug Resistance Workshop 2006Mark Mascolini, Charles Boucher, Brendan Larder, et al.
Journal of Virology|August 19, 2011
Upregulation of BST-2/Tetherin by HIV infection in vivoStefanie Homann, Davey Smith, Susan Little, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infectionDennis Sheeter, Pinyi Du, Steffney Rought, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutationsFatih M Uckun, Sharon Pendergrass, T K Venkatachalam, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|March 29, 2019
A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinibKatya Prakash, Douglas Richman
Current Opinion in HIV and AIDS|April 9, 2013
How to best measure HIV reservoirs?Christine Rouzioux, Douglas Richman
Antiviral Therapy|October 31, 2022
Preface: Special Collection Commemorating John C. MartinStephen Locarnini, Douglas Richman, Richard Whitley
Open Forum Infectious Diseases|July 24, 2019
<i>Myroides injenensis</i> Bacteremia and Severe CellulitisStephanie LaVergne, Thaidra Gaufin, Douglas Richman
AIDS Research and Human Retroviruses|March 20, 2003
A new perspective on V3 phenotype predictionSatish Pillai, Benjamin Good, Douglas Richman, et al.
Antiviral Therapy|September 13, 2006
The XIVth International HIV Drug Resistance Workshop, Quebec City, Canada, June 2005Charles Boucher, Brendan Larder, John Mellors, et al.
Antiviral Therapy|May 17, 2007
Key reports from the XV International HIV Drug Resistance Workshop 2006Mark Mascolini, Charles Boucher, Brendan Larder, et al.
Journal of Virology|August 19, 2011
Upregulation of BST-2/Tetherin by HIV infection in vivoStefanie Homann, Davey Smith, Susan Little, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infectionDennis Sheeter, Pinyi Du, Steffney Rought, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutationsFatih M Uckun, Sharon Pendergrass, T K Venkatachalam, et al.
Pageof 5